The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFEET.L Regulatory News (FEET)

  • There is currently no data for FEET

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposal to Liquidate

14 Sep 2022 07:00

RNS Number : 3575Z
Fundsmith Emerging Equities Tst PLC
14 September 2022
 

Fundsmith Emerging Equities Trust plc

 

14 September 2022

 

Proposal to Liquidate

 

The Board of Fundsmith Emerging Equities Trust plc ('the Company') announces that, following notification from Fundsmith LLP (the investment manager and AIFM of the Company) that it intends to give notice under the investment management agreement, proposals will be put forward for the Company to be placed into voluntary liquidation, with the cash proceeds arising on realisation of the portfolio returned to shareholders. The Board has sought the views of its largest shareholders and its professional advisors and believes that the proposals are in the best interests of shareholders as a whole.

The Company will publish a Circular shortly setting out details of the proposals to place the Company into members' voluntary liquidation, appoint a liquidator, and delist the Company. The Company will convene a General Meeting at which approval will be sought from shareholders. It is anticipated that, if approval is forthcoming, the Company is expected to be placed into voluntary liquidation by the end of November.

The Board will recommend that shareholders vote in favour of the proposals. The Board will vote their shares (112,250 - 0.43%[1]) in favour of the resolutions. The Board has also received indications from Fundsmith LLP that partners and staff of the firm will vote their shares (1,379,227 - 5.25%1) in favour of the resolutions.

Terry Smith, CEO and CIO of Fundsmith LLP, commented: "We have always maintained that we would only run funds where we felt we had a particular edge that would allow us to deliver superior risk-adjusted returns. Whilst FEET has made a positive return since launch in 2014 it has fallen below our expectations and, unlike other fund managers who might seek to hold onto the fund for the sake of the fee income, we feel it would be in the best interests of shareholders to receive their investment back in cash through a liquidation of the portfolio and wind-up of the Company."

Martin Bralsford, Chairman of the Board, commented: "We would like to thank Terry and his team for the diligent effort they have made over the last eight years as Investment Manager. W believe it to be in the best interests of shareholders as a whole to liquidate the portfolio and return their cash to them."

This announcement contains inside information for the purposes of Article 7 of Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 and as amended ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

For further information please contact:Charlotte Balbirnie+44 (0)7989 528421 CBalbirnie@keplercomms.com

 

 

Mark Pope

Frostrow Capital LLP

Company Secretary

+44 (0) 203 008 4913

mark.pope@frostrow.com

 


[1] Calculated as a percentage of those 26,288,283 ordinary shares eligible to vote, i.e. the issued share capital, less the number of shares held in treasury.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCEAANDFLLAEAA
Date   Source Headline
11th Nov 20221:03 pmRNSResults of the General Meeting
2nd Nov 20221:19 pmRNSMonthly Fact Sheet as at 31 October 2022
1st Nov 20229:37 amRNSTotal Voting Rights
11th Oct 20227:21 amRNSPublication and Posting of Circular
5th Oct 20229:44 amRNSMonthly Fact Sheet as at 30 September 2022
3rd Oct 20227:30 amRNSTotal Voting Rights
21st Sep 20221:02 pmRNSHolding(s) in Company
14th Sep 20228:25 amRNSProposal to Liquidate (Replacement)
14th Sep 20227:00 amRNSProposal to Liquidate
2nd Sep 202212:16 pmRNSMonthly Fact Sheet as at 31 August 2022
1st Sep 20229:29 amRNSTotal Voting Rights
5th Aug 20227:00 amRNSHalf-year Report
2nd Aug 202211:04 amRNSMonthly Fact Sheet as at 29 July 2022
1st Aug 202210:20 amRNSTotal Voting Rights
7th Jul 202212:08 pmRNSBlock listing Interim Review
5th Jul 20229:47 amRNSCompliance with Market Abuse Regulation
4th Jul 20221:38 pmRNSMonthly Fact Sheet as at 30 June 2022
1st Jul 202212:49 pmRNSTotal Voting Rights
8th Jun 20222:09 pmRNSDirector/PDMR Shareholding
6th Jun 20222:33 pmRNSMonthly Fact Sheet as at 31 May 2022
1st Jun 202210:29 amPRNNet Asset Value(s)
1st Jun 20227:27 amRNSTotal Voting Rights
31st May 202210:09 amPRNNet Asset Value(s)
30th May 202210:22 amPRNNet Asset Value(s)
27th May 20221:16 pmRNSDirector/PDMR Shareholding
27th May 20229:34 amPRNNet Asset Value(s)
26th May 20229:47 amPRNNet Asset Value(s)
25th May 20224:45 pmRNSResult of AGM
25th May 20222:56 pmRNSDirectorate Change
25th May 202210:01 amPRNNet Asset Value(s)
24th May 202210:23 amPRNNet Asset Value(s)
23rd May 20229:52 amPRNNet Asset Value(s)
10th May 20224:47 pmRNSHolding(s) in Company
9th May 202210:35 amRNSMonthly Fact Sheet as at 29 April 2022
3rd May 202210:31 amRNSTotal Voting Rights
14th Apr 202210:24 amPRNNet Asset Value(s)
13th Apr 202210:21 amPRNNet Asset Value(s)
12th Apr 202211:00 amPRNNet Asset Value(s)
11th Apr 202210:47 amPRNNet Asset Value(s)
8th Apr 202210:17 amPRNNet Asset Value(s)
7th Apr 202210:27 amPRNNet Asset Value(s)
6th Apr 202210:38 amPRNNet Asset Value(s)
5th Apr 202210:50 amPRNNet Asset Value(s)
4th Apr 20221:52 pmRNSMonthly Fact Sheet as at 31 March 2022
4th Apr 202210:54 amPRNNet Asset Value(s)
1st Apr 202210:27 amPRNNet Asset Value(s)
1st Apr 20228:41 amRNSTotal Voting Rights
31st Mar 202210:43 amPRNNet Asset Value(s)
30th Mar 202210:27 amPRNNet Asset Value(s)
29th Mar 202210:13 amPRNNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.